Medical News


Archive for December, 2007

Treating of ignored non-cancer health issues

Receiving therapy for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates as per a research studyreported in the December 20 issue of the Journal of Clinical Oncology. The study, by scientists from the Indiana University School of Medicine, the Regenstrief Institute and the Roudebush Veterans Administration Medical Center, is the first to look at the effect of primary care on health outcomes in cancer patients……..

Original post by Health news from medicineworld.org

Read entire article

No comments

Cost of glaucoma medications may impact treatment

In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated 38% to 52% of the total. In an article reported in the January 2008 issue of the American Journal of Ophthalmology, scientists from The Texas AandM University System Health Science Center College of Medicine, Temple, Texas; analyzed the economics of medically managing glaucoma. The yearly costs to patients of various topical glaucoma medications were calculated and significant price differences and increases in cost over time were found……..

Original post by Health news from medicineworld.org

Read entire article

No comments

LASIK works well in highly myopic patients

Laser surgery to correct vision problems has been in use since the early part of 1990s. Photorefractive Keratotomy (PRK) is typically used to correct low to moderate myopia, while laser in-situ keratomileusis (LASIK) is preferred for high myopia corrections. Eventhough over 18 million LASIK procedures have been performed worldwide, there is still some controversy regarding the maximum correction possible and efficacy with this technique. In an article reported in the January 2008 issue of the American Journal of Ophthalmology, scientists from Miguel Hernandez University, Medical School, Alicante, Spain; and Ankara University School of Medicine, Ankara, Turkey; report on a study of high myopia patients ten years after LASIK surgery. The findings show that LASIK for myopia over -10 D is a safe and effective procedure in the long-term……..

Original post by Health news from medicineworld.org

Read entire article

No comments

Handling pesticides associated with asthma

New research on farm women has shown that contact with some usually used pesticides in farm work may increase their risk of allergic asthma. Farm women are an understudied occupational group, said Jane Hoppin, Sc.D., of the National Institute of Environmental Health Sciences and lead author of the study. More than half the women in our study applied pesticides, but there is very little known about the risks……..

Original post by Health news from medicineworld.org

Read entire article

No comments

NeuroMEDx Receives Another Patent for Parkinson’s, Epilepsy, and Depression Therapies

St. Cloud, MN July 21, 2004 — NeuroMEDx, an early stage medical device company located in St. Cloud, MN, focused on the treatment of neurologic disorders, has been issued patent #6,764,498 from the United States Patent and Trademark Office. This is the second patent the company has received for implantable devices to treat disorders such as Parkinson’s Disease, Epilepsy, and depression. In addition to providing an alternative to surgery and drug therapies, NeuroMEDx’ MED(Mechanoelectric Device)technology may be a viable option to other device-based treatments offered by Medtronic(MDT), Cyberonics(CYBX), Advanced Neurologic Systems(ANSI), Guidant(GDT) and St. Jude(STJ). The MED technology is implanted using standard minimally invasive procedures.
The company also has patents pending that leverage the MED technology in treating disorders of the cardiac and central nervous systems.

Contact Information:

Hans Mische
1 612 987 0249
patriot@cloudnet.com

Read entire article

No comments

One in Five people affected by irritable bowel syndromes

As scientific evidence grows of the ability of certain food ingredients to benefit human health, more and more products
are being launched claiming to have beneficial effects on gastrointestinal (gut) health and well-being in general. This is
against a background where colorectal cancer is one of the most common causes of cancer death, accounting for approximately
12-13% of deaths from all cancers and where up to 20% of the general population is affected at some time or another by irritable bowel syndrome.

This report, consisting of over 150 pages, over 60 tables and 28 colour product shots, is the second in a unique series of reports
on the global functional foods market. Following on the heels of a major study on the world market for heart benefit foods, this global
analysis on the market for gut benefit foods gives an invaluable insight into the commercial, societal and technical drivers shaping its
development. The report will help you track developments in a highly dynamic sector of the food market, identify new business
opportunities, identify new ingredients with gut health properties and prepare your business strategy.

Key features

- Highlights current and future directions in gut benefit foods and associated ingredients technology
- Analyses market sizes and trends in Europe, the USA, Japan and Australia
- Reviews key new product activity in gut benefit foods worldwide
- Reviews prevalence of gastrointestinal disorders by country and trends in incidence
- Discusses future trends and prospects
- Presents 28 colour shots of key products

For a complete index of this report click on http://www.researchandmarkets.com/reports/40116

About Research and Markets Ltd.
Research and Markets Ltd. are Europe’s largest resource for market research. R&M distribute thousands of major
research publications from the world’s leading publishers, consultants and market analysts. R&M provide you with the
latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their
web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com

Read entire article

No comments

High triglycerides, other cholesterol raise risk of stroke

People with high triglycerides and another type of cholesterol tested but not commonly reviewed as part of a persons risk assessment have an increased risk of a certain type of stroke, as per research reported in the December 26, 2007, online issue of Neurology, the medical journal of the American Academy of Neurology……..

Original post by Health news from medicineworld.org

Read entire article

No comments

« Previous PageNext Page »